Aprogen Medicines Market Cap

Aprogen Medicines has a market cap or net worth of 52.6 billion as of June 23, 2026. Its market cap has decreased by -74.04% in one year.

Market Cap

52.60B

Enterprise Value

489.45B

Revenue

127.54B

Ranking

n/a

PE Ratio

n/a

Stock Price

2,375.00

Market Cap Chart

Since December 7, 1995, Aprogen Medicines's market cap has increased from 19.56B to 52.60B, an increase of 168.93%. That is a compound annual growth rate of 3.29%.

Market Cap History

Date	Market Cap	% Change
Jun 23, 2026	52.60B	-75.54%
Dec 30, 2025	215.06B	-2.20%
Dec 30, 2024	219.89B	-6.16%
Dec 28, 2023	234.32B	-41.38%
Dec 27, 2022	399.71B	19.11%
Dec 30, 2021	335.57B	-10.30%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Hyundai Futurenet	329.79B
KPX Holdings	323.01B
KG Chemical	299.86B
HS HYOSUNG	190.50B
Woongjin	160.48B
JLK, Inc.	126.93B
Gridwiz	119.14B
HLB GLOBAL	77.25B

Market Cap Rankings